These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16099467)

  • 1. Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
    Rainbow RD; Norman RI; Hudman D; Davies NW; Standen NB
    J Mol Cell Cardiol; 2005 Oct; 39(4):637-46. PubMed ID: 16099467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
    Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
    J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels.
    Lawrence CL; Rainbow RD; Davies NW; Standen NB
    Br J Pharmacol; 2002 Jul; 136(5):746-52. PubMed ID: 12086984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels.
    Manning Fox JE; Kanji HD; French RJ; Light PE
    Br J Pharmacol; 2002 Jan; 135(2):480-8. PubMed ID: 11815384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracellular MgADP and acidification on the inhibition of cardiac sarcolemmal ATP-sensitive potassium channels by propofol.
    Yamada H; Kawano T; Tanaka K; Yasui S; Mawatari K; Takahashi A; Nakaya Y; Oshita S
    J Anesth; 2007; 21(4):472-9. PubMed ID: 18008114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes.
    Rainbow RD; Lodwick D; Hudman D; Davies NW; Norman RI; Standen NB
    J Physiol; 2004 Jun; 557(Pt 3):785-94. PubMed ID: 15020694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels.
    Sukhodub A; Jovanović S; Du Q; Budas G; Clelland AK; Shen M; Sakamoto K; Tian R; Jovanović A
    J Cell Physiol; 2007 Jan; 210(1):224-36. PubMed ID: 17044064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
    Babenko AP; Gonzalez G; Aguilar-Bryan L; Bryan J
    Circ Res; 1998 Nov; 83(11):1132-43. PubMed ID: 9831708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
    Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
    Gonca E; Bozdogan O
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):403-11. PubMed ID: 20693159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
    Weyermann A; Vollert H; Busch AE; Bleich M; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):374-81. PubMed ID: 15024553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazoxide maintenance of myocyte volume and contractility during stress: evidence for a non-sarcolemmal K(ATP) channel location.
    Sellitto AD; Maffit SK; Al-Dadah AS; Zhang H; Schuessler RB; Nichols CG; Lawton JS
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1153-9. PubMed ID: 20804990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death.
    Englert HC; Heitsch H; Gerlach U; Knieps S
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):253-71. PubMed ID: 15326916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and pharmacological characterization of sarcolemmal ATP-sensitive potassium channels in the murine atrial HL-1 cell line.
    Fox JE; Jones L; Light PE
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):30-5. PubMed ID: 15613976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098.
    Kääb S; Zwermann L; Barth A; Hinterseer M; Englert HC; Gögelein H; Näbauer M
    Cardiovasc Drugs Ther; 2003; 17(5-6):435-41. PubMed ID: 15107598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.